InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-17.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by LINDSTROM RICHARD L MD, Director. Insider active across 5 companies, notably Harrow Health, INC.. Aggregated, 17 reports have been logged. Split: 1 buy · 9 sells. Total volume traded: €1.3m. History available since 20 May 2021. The latest transaction was filed on 8 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
10,000 shares@ US$6.9613.5% of flowCommon StockSEC:0001104659-25-047435:0
Ideal exit: 2 Feb 2026 (T+270)
18,939 shares@ US$8.8033.3% of flowCommon StockSEC:0001104659-24-083104:0
22,000 shares0Common StockSEC:0000950170-24-057107:0
12,000 shares0Common StockSEC:0001104659-23-072402:0
9,288 shares0Common StockSEC:0000899243-23-014072:0
40,000 shares@ US$12.6278.3% of flowCommon StockSEC:0001493152-22-027463:0
8,933 shares0Common StockSEC:0001104659-22-073148:0
4,285 shares0Common StockSEC:0000899243-22-020012:0
9,469 shares@ US$1.220.0006% mcap4.5% of flowCommon StockSEC:0001104659-22-061322:0
3,900 shares@ US$10.045.1% of flowCommon StockSEC:0001493152-21-023910
3,900 shares@ US$10.040.0018% mcap10.5% of flowCommon StockSEC:0001493152-21-023910:0
14,160 shares@ US$9.090.0060% mcap34.2% of flowCommon StockSEC:0001493152-21-023036:0
14,160 shares@ US$9.0916.6% of flowCommon StockSEC:0001493152-21-023036
10,000 shares@ US$14.3047.7% of flowCommon StockSEC:0001104659-21-070642
10,000 shares@ US$10.7527.6% of flowCommon StockSEC:0001493152-21-012566
10,000 shares@ US$10.750.0048% mcap27.6% of flowCommon StockSEC:0001493152-21-012566:0
10,000 shares@ US$14.300.0058% mcap47.7% of flowCommon StockSEC:0001104659-21-070642:0
17 of 17 declarations
About LINDSTROM RICHARD L MD
Richard L. Lindstrom, MD is a Board Member at Harrow Health, Inc. and Ocular Therapeutix, Inc., where he contributes to the governance and strategic direction of the companies. As a board member, he is involved in important decision-making and overseeing operations. His experience in the healthcare sector is a valuable asset.
